Nanobiotix S.A. (NASDAQ:NBTX – Get Free Report) traded down 1% during mid-day trading on Friday . The company traded as low as $2.82 and last traded at $2.83. 44,226 shares traded hands during trading, an increase of 18% from the average session volume of 37,454 shares. The stock had previously closed at $2.86.
Nanobiotix Trading Down 1.0 %
The company’s 50-day moving average is $3.38 and its 200 day moving average is $4.52.
Nanobiotix Company Profile
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Featured Articles
- Five stocks we like better than Nanobiotix
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- The Significance of Brokerage Rankings in Stock Selection
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
